Magnesium retards the progress of the arterial calcifications in hemodialysis patients: a pilot study

International Urology and Nephrology

Volumn 46, Issue 11, 2014, Pages 2199-2205

  Tzanakis, Ioannis P ^a,d   Stamataki, Elisavet E ^a,d   Papadaki, Antonia N ^a,d   Giannakis, Nektarios ^b,d   Damianakis, Nikolaos E ^b,d   Oreopoulos, Dimitrios G ^c,d  

^a Chania General Hospital   (Greece)

^b Chania General Hospital   (Greece)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d General Hospital of Chania   (Greece)

Author keywords

Arteries; Calcifications; Hemodialysis; Magnesium

Indexed keywords

CALCIUM ACETATE; MAGNESIUM CARBONATE; MAGNESIUM;

ADULT; ARTERY CALCIFICATION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VASCULAR CALCIFICATION SCORE; X RAY; ADVERSE EFFECTS; AGED; DOSE RESPONSE; KIDNEY FAILURE, CHRONIC; ORAL DRUG ADMINISTRATION; PERIPHERAL ARTERIAL DISEASE; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME; VASCULAR CALCIFICATION;

ADMINISTRATION, ORAL; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNESIUM; MALE; PERIPHERAL ARTERIAL DISEASE; PILOT PROJECTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TREATMENT OUTCOME; VASCULAR CALCIFICATION;

EID: 84909995766     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-014-0751-9     Document Type: Article

References (29)

1. Foley RN, Parfrey PS (1998) Cardiovascular disease and mortality in ESRD. J Nephrol 11:239–245
2. Speer MY, Giachelli CM (2004) Regulation of cardiovascular calcification. Cardiovasc Pathol 13:63–70
3. Rayssiguier Y (1986) Magnesium, lipids and vascular diseases. Experimental evidence in animal models. Magnesium 5(3–4):182–190
4. Cohen H, Sherer Y, Shaish A, Shoenfeld Y, Levkovitz H, Bitzur R et al (2002) Atherogenesis inhibition induced by magnesium-chloride fortification of drinking water. Biol Trace Elem Res 90(1–3):251–259
5. Schwille PO, Schmiedl A, Schwille R, Brunner P, Kissler H, Cesnjevar R et al (2003) Media calcification, low erythrocyte magnesium, altered plasma magnesium, and calcium homeostasis following grafting of the thoracic aorta to the infrarenal aorta in the rat differential preventive effects of long-term oral magnesium supplementation alone and in combination with alkali. Biomed Pharmacother 57(2):88–97
6. Kircelli F, Peter ME, Ok ES, Celenk FG, Yilmaz M, Steppan S et al (2012) Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 27:514–521
7. Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A et al (2012) Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol 35(1):31–39
8. Louvet L, Büchel J, Steppan S, Passlick-Deetjen J, Massy ZA (2013) Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 28:869–878
9. Meema HE, Oreopoulos DG, Rapoport A (1987) Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 32:388–394
10. Tzanakis I, Pras A, Kounali D, Mamali V, Kartsonakis V, Mayopoulou-Symvoulidou D et al (1997) Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant 12(9):2036–2037
11. Tzanakis I, Virvidakis K, Tsomi A, Mantakas E, Girousis N, Karefyllakis N et al (2004) Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res 17(2):102–108
12. Ishimura E, Okuno S, Kitatani K, Tsuchida T, Yamakawa T, Shioi A, Inaba M, Nishizawa Y (2007) Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol 68(4):222–227
13. Spiegel DM, Farmer B (2009) Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: a pilot study. Hemodial Int 13:453–459
14. Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y (2007) Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res 20(4):237–244
15. Tzanakis I, Tsomi A, Mantakas E, Papadaki A, Kallivretakis N (2006) The higher intracellular magnesium, the better long-term survival on hemodialysis. Presented in ASN Congress (Renal Week) November 14–19 2006, San Diego, USA
16. Lacson EK, Wang W, Lazarus M, Hakim R (2009) Magnesium and mortality risk in hemodialysis patients. Presented in ASN Congress (Renal Week), October 27–November 1, 2009, San Diego, USA
17. Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU et al (2012) Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 36(3):228–237
18. Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M et al (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19:1480–1488
19. Adragão T, Pires A, Birne R, Curto JD, Lucas C, Gonçalves MA et al (2009) A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients. Nephrol Dial Transplant 24:997–1002
20. Adragao T, Pires A, Branco P, Curto JD, Lucas C, Gonçalves M et al (2012) Ankle–brachial index, vascular calcifications and mortality in dialysis patients. Nephrol Dial Transplant 27(1):318–325
21. Wei M, Esbaei K, Bargman JM, Oreopoulos DG (2006) Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to a dynamic bone disease? Int Urol Nephrol 38:317–322
22. Contiguglia SR, Alfrey AC, Miller NL, Runnells DE, Le Geros RZ (1973) Nature of soft tissue calcification in uremia. Kidney Int 4:229–235
23. Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM (2008) Exploring the biology of vascular calcification in chronic kidney disease: what’s circulating? Kidney Int 73:384–390
24. Bennett RM, Lehr JR, McCarty DJ (1975) Factors affecting the solubility of calcium pyrophosphate dehydrate crystals. J Clin Invest 56:1571–1579
25. Massy Ziad A, Drueke Tilman B (2012) Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J 5(Suppl 1):i52–i61
26. Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H (2001) Vascular calcification and inorganic phosphate. Am J Kidney Dis 38:34–37
27. Shanahan CM (2005) Mechanisms of vascular calcification in renal disease. Clin Nephrol 63:146–157
28. Moe SM, Drueke T, Lameire N, Eknoyan G (2007) Chronic kidney disease mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis 14:3–12
29. De Schutter TM, Behets GJ, Geryl H, Peter ME, Steppan S, Gundlach K (2013) Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia. Kidney Int 83(6):1109–1117